Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Denny Ware
AddedMar 31, 2024
UpdatedMay 31, 2026
Denny Ware

Denny Ware

Board Member, Pelikan Technologies

Crunchbase

Denny Ware's Career

Pelikan Technologies
Pelikan Technologies

Palo Alto, CA, US

Board Member· Board
CeloNova Biosciences
CeloNova Biosciences

San Antonio, TX, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Denny Ware's Career

Pelikan Technologies
Pelikan Technologies
Public$137.2M1252001Palo Alto, CA, US
Board Member· Board

Leadership at Pelikan Technologies

Dennis HennerDennis HennerBoard Member
GERALD MOELLERGERALD MOELLERBoard Member

Similar to Pelikan Technologies

GluconGluconBoulder, CO, USMedical Devicesest. 2000GluconBoulder, CO, US · est. 2000

Glucon develops superior, patent-protected, photoacoustic glucose monitoring devices for diabetes care.

Series D · $25.6M5
Pocket ClinicPocket ClinicCentral Falls, RI, USMedical Devicesest. 2016Pocket ClinicCentral Falls, RI, US · est. 2016

Med-tech firm innovating daily-use devices for accurate, sustainable diabetes management.

Seed · $140k5
DexcomDexcomSan Diego, CA, USGlucose Monitors, Medical Devicesest. 1999DexcomSan Diego, CA, US · est. 1999

Dexcom, Inc.: A San Diego-based medical device company specializing in continuous glucose monitoring systems for diabetics.

Public · $1.4B7.6k
Senseonics HoldingsSenseonics HoldingsGermantown, MD, USGlucose Monitoringest. 2015Senseonics HoldingsGermantown, MD, US · est. 2015

US-based Senseonics Holdings, Inc. designs, develops, and commercializes glucose monitoring systems.

Public121
CeloNova Biosciences
CeloNova Biosciences
Acquired$20.8M02000San Antonio, TX, US
Board Member· Board

Leadership at CeloNova Biosciences

Tim LylesTim LylesBoard Member
Harry R. JacobsonHarry R. JacobsonBoard Member
Goetz RichterGoetz RichterFounder
Marty LandonMarty LandonBoard Member

Denny Ware's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Denny Ware

Carl St. BernardCarl St. BernardCEO · Tryton MedicalDrew SenyeiDrew SenyeiBoard Member · CelulaRobert HaririRobert HaririCo-Founder · CelgeneRene ReinsbergRene ReinsbergCo-Founder · CeloRobert GuerreroRobert GuerreroBoard Member · ProteoNova